Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is

Shizhen Emily Wang1, Frederick Y Wu, Incheol Shin

  • 1Division of Oncology, Department of Cancer Biology, Vanderbilt University School of Medicine, 2220 Pierce Ave., 777 PRB, Nashville, TN 37232-6307, USA.

Insights

Transforming growth factor beta (TGF-beta) and HER2 signaling converge on protein tyrosine phosphatase receptor type kappa (PTPRK). PTPRK is essential for TGF-beta

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Transforming growth factor beta (TGF-beta) is known to inhibit proliferation and promote cell migration.
  • HER2 overexpression is implicated in various cellular processes, including mammary epithelial cell behavior.

Purpose of the Study:

  • To identify novel Smad targets in TGF-beta-treated MCF10A mammary epithelial cells overexpressing HER2.
  • To elucidate the role of protein tyrosine phosphatase receptor type kappa (PTPRK) in TGF-beta and HER2 signaling pathways.

Main Methods:

  • Chromatin immunoprecipitation was used to identify Smad targets.
  • RNA interference (RNAi) was employed to study the function of PTPRK.
  • Western blotting and quantitative PCR were utilized to assess protein and mRNA expression levels.
  • Cell proliferation, cell cycle progression, and cell motility assays were performed.

Main Results:

  • PTPRK was identified as a novel Smad target, with TGF-beta up-regulating its expression and HER2 overexpression down-regulating it.
  • RNAi of PTPRK accelerated cell cycle progression, enhanced EGF response, and abrogated TGF-beta-mediated antimitogenesis.
  • RPTPkappa (the protein product of PTPRK) associated with EGFR and HER2, suppressing proliferation and receptor phosphorylation.
  • TGF-beta-induced cell motility, FAK phosphorylation, and F-actin assembly were dependent on RPTPkappa.
  • RPTPkappa positively regulates Src, with convergence of HER2 and TGF-beta signaling at Src.

Conclusions:

  • RPTPkappa is a key mediator of both the antiproliferative and promigratory effects of TGF-beta.
  • HER2 signaling and TGF-beta-induced RPTPkappa converge at Src, influencing cell motility and adhesion.
  • PTPRK plays a critical role in regulating mammary epithelial cell behavior in response to TGF-beta and HER2 signaling.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...